Literature DB >> 14708679

Hepatitis B virus and hepatocellular carcinoma.

Jordi Bruix1, Josep M Llovet.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14708679     DOI： 10.1016/s0168-8278(03)00140-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  21 in total

Review 1.  Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.

Authors:  Xiao-Jun Lin; Xiang-Ming Lao; Ming Shi; Sheng-Ping Li
Journal:  Dig Dis Sci       Date:  2016-04-22       Impact factor: 3.199

2.  Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

Authors:  Hiromi Yatsuji; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; Michio Imamura; Shoichi Takahashi; Eiji Iwao; Yoshifumi Fujimoto; Hidenori Ochi; Hiromi Abe; Toshiro Maekawa; Chise Tateno; Katsutoshi Yoshizato; Fumitaka Suzuki; Hiromitsu Kumada; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

3.  Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.

Authors:  Masataka Tsuge; Takuro Uchida; Nobuhiko Hiraga; Hiromi Kan; Grace Naswa Makokha; Hiromi Abe-Chayama; Daiki Miki; Michio Imamura; Hidenori Ochi; C Nelson Hayes; Rieko Shimozono; Tomokatsu Iwamura; Hideki Narumi; Tomohiko Suzuki; Mie Kainoh; Tadatsugu Taniguchi; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Importance of serum concentration of adefovir for Lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.

Authors:  Fukiko Mitsui; Masataka Tsuge; Takashi Kimura; Shosuke Kitamura; Hiromi Abe; Hiromi Saneto; Tomokazu Kawaoka; Daiki Miki; Tsuyoshi Hatakeyama; Nobuhiko Hiraga; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Shoichi Takahashi; C Nelson Hayes; Harue Igarashi; Kentaro Morimoto; Masao Shimizu; Kazuaki Chayama
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

5.  MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.

Authors:  Kun He; Zemin Hu; Jiahou Ruan; Qianhong Ma; Feng Zhong; Xinsheng Cheng; Shibo Sun; Jie Zhou
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.

Authors:  Zheng Li; Zhengqing Lei; Yong Xia; Jun Li; Kui Wang; Han Zhang; Xuying Wan; Tian Yang; Weiping Zhou; Mengchao Wu; Timothy M Pawlik; Wan Yee Lau; Feng Shen
Journal:  JAMA Surg       Date:  2018-10-17       Impact factor: 14.766

7.  Rational design leads to more potent RNA interference against hepatitis B virus: factors effecting silencing efficiency.

Authors:  Kathy Keck; Esther M Volper; Ryan M Spengler; Dang D Long; Chi Y Chan; Ye Ding; Anton P McCaffrey
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

8.  Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.

Authors:  Masataka Tsuge; Nobuhiko Hiraga; Takuro Uchida; Hiromi Kan; Eisuke Miyaki; Keiichi Masaki; Atsushi Ono; Takashi Nakahara; Hiromi Abe-Chayama; Yizhou Zhang; Makokha Grace Naswa; Tomokazu Kawaoka; Daiki Miki; Michio Imamura; Yoshiiku Kawakami; Hiroshi Aikata; Hidenori Ochi; C Nelson Hayes; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2016-03-04       Impact factor: 7.527

9.  A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Jie Peng; Jing Zhang; Qifan Zhang; Yikai Xu; Jie Zhou; Li Liu
Journal:  Diagn Interv Radiol       Date:  2018 May-Jun       Impact factor: 2.630

10.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.